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Abstract
Background: Estrogens are reported to increase type I and type III collagen deposition and to
regulate Metalloproteinase 2 (MMP-2) expression. These proteins are reported to be dysregulated
in incisional hernia formation resulting in a significantly decreased type I to III ratio. We aimed to
evaluate the β-estradiol mediated regulation of type I and type III collagen genes as well as MMP-2
gene expression in fibroblasts derived from patients with or without history of recurrent incisional
hernia disease. We compared primary fibroblast cultures from male/female subjects without/
without incisional hernia disease.
Results: Incisional hernia fibroblasts (IHFs) revealed a decreased type I/III collagen mRNA ratio.
Whereas fibroblasts from healthy female donors responded to β-estradiol, type I and type III gene
transcription is not affected in fibroblasts from males or affected females. Furthermore β-estradiol
had no influence on the impaired type I to III collagen ratio in fibroblasts from recurrent hernia
patients.
Conclusion: Our results suggest that β-estradiol does not restore the imbaired balance of type I/
III collagen in incisional hernia fibroblasts. Furthermore, the individual was identified as an
independent factor for the β-estradiol induced alterations of collagen gene expression. The
observation of gender specific β-estradiol-dependent changes of collagen gene expression in vitro
is of significance for future studies of cellular response.
Background
An impaired collagen metabolism is hypothesized to dis-
turb the wound healing process with the consequence of
hernia formation and hernia recurrence. In vivo studies of
hernia patients revealed irregularly arranged collagen fib-
ers, disturbed collagen hydroxylation and an altered colla-
gen framework resulting in increased tissue elasticity [1].
Analysis of the extracellular matrix in patients with either
primary or recurrent incisional hernias revealed altera-
tions in type I and type III collagen gene expression: a
decreased ratio with increased type III collagen protein
was detected in incisional hernia patients and was con-
firmed at the transcript level [2,3]. Alterations of the col-
lagen composition may occur due to changes in collagen
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degrading proteases may represent key factors. Bellon et
al. have suggested that high expression levels of metallo-
proteinase 2 (MMP-2) play a pathogenetic role for direct
inguinal hernia formation [4].
Age above 45 years and male gender are dominant demo-
graphic factors that correlate with the incidence of inci-
sional hernia disease and collagen metabolism [5].
Collagen content is significantly decreased in women who
have pelvic organ prolapse regardless of age, parity, body
mass index, or tobacco use [6]. Furthermore estrogen is a
major regulator of wound healing that can reverse age-
and sex-related impaired wound healing in human and
animal models, characterized by a dampened inflamma-
tory response and increased matrix deposition [7]. Several
studies have demonstrated estrogen-mediated effects on
collagen and MMP-2 metabolism [8]. Topical estrogen
treatment in both males and females decreased wound
size with increased collagen levels and enhanced tensile
strength [7]. Jorgensen et al. reported increased collagen
deposition in premenopausal women after subcutaneous
implantation of expanded poly-tetra-fluorethylene test
tubes compared to postmenopausal women [9]. Further-
more estrogens influence MMP-2 expression, as MMP-2
levels are reduced after treatment with estrogen in ovariec-
tomized rats [10].
The aim of the present study was to evaluate the immedi-
ate effect of β-estradiol on type I and III collagen as well as
MMP-2 gene expression in the principal cell type respon-
sible for wound healing that is the fibroblast. An in vitro
model system was established with primary fibroblast cul-
tures from patients with and without recurrent incisional
hernia disease.
Results
Collagen type IA1 and IIIA1 expression levels in fibrob-
lasts from patients with recurrent incisional hernia disease
compared to control fibroblasts
The type IA1/IIIA1 collagen ratio was significantly
decreased in fibroblasts from male and female patients
with incisional hernia disease (14. 5 +/- 7. 0 after 24 hours
and 17.9+/- 11. 2 after 48 hours) compared to control
fibroblasts from patients without recurrent hernia disease
(47. 2 +/- 9. 6 after 24 hours and 50. 6 +/- 9. 2 after 48
hours; Figure 1).
Changes of collagen expression by β-estradiol stimulation
Stimulation with 0.025 ng/ml and 0.25 ng/ml β-estradiol
for 24 hours led to increased type IA1 and type IIIA1 col-
lagen mRNA expression levels in fibroblasts from the
female control patient (Type IA1 collagen: 1. 36 +/- 0. 21
after 0. 025 ng/ml β-estradiol and 1. 4 +/- 0. 38 after 0.25
ng/ml; Type IIIA1 collagen: 1. 25 +/- 0. 26 after 0.025 ng/
ml β-estradiol and 1.44 +/- 0. 07 after 0.25 ng/ml; Figure
2A). This effect lasted for more than 48 hours, however no
differences could be detected for the different concentra-
tions of β-estradiol (Type IA1 collagen: 1. 31 +/- 0. 13 after
0. 025 ng/ml β-estradiol and 1. 17 +/- 0. 14 after 0.25 ng/
ml; Type IIIA1 collagen: 1. 44 +/- 0. 41 after 0.025 ng/ml
β-estradiol and 1.28 +/- 0. 32 after 0.25 ng/ml; Figure 2B).
Stimulation with β-estradiol had no effect on type IA1 and
type IIIA1 collagen expression in male control fibroblasts
(CF) and female incisional hernia fibroblasts (IHF) (Fig-
ure 3). Exclusively, male hernia fibroblasts showed high
levels of type IIIA1 collagen after stimulation with 0.25
ng/ml β-estradiol for 24 h (1.6 +/- 0. 35 fold increase). The
type IA1/III collagen mRNA ratio was significantly lower
in fibroblasts derived from patients with incisional hernia
disease, both female and male (male IHF vs male CF: 14.
28 +/- 7. 5 vs. 50. 34 +/- 8. 1, p < 0. 05; female IHF vs.
female CF: 14. 65 +/- 5. 46 vs. 43. 89 +/- 8. 62), and this
ratio was not affected by stimulation with 0.025 and 0.25
ng/ml β-estradiol (Male IHF: 19. 36 +/- 12. 02 and 7. 92
+/- 4. 05; female IHF: 15. 05 +/- 4. 75 and 16. 16 +/- 8. 01;
Figure 4). Similarly β-estradiol had no influence on the
type IA1/III collagen mRNA ratio in control fibroblasts
(Figure 4).
Alterations of MMP-2 expression and enzyme activities in
primary fibroblast cultures from patients with recurrent
incisional hernia disease compared to control fibroblasts
The MMP-2 mRNA expression was significantly lower in
female and male IHFs compared to CFs (2. 32 pg +/- 0.09
and 2. 65 pg +/- 0.34 in CFs vs 0. 21 pg +/- 0.04 and 1. 66
pg +/- 1 in IHFs; Figure 5A and 5B). Stimulation with 0.25
Type I to type III collagen gene expression in primary fibrob-lastsFigure 1
Type I to type III collagen gene expression in primary fibrob-
lasts. Type I/III collagen mRNA (ratio) was quantified by RT-
PCR analysis. White bars: CFs (fibroblasts derived from 
patients without incisional hernia); black bars: IHFs (fibrob-
lasts from patients with recurrent incisional hernias). Data 
are presented as means +/- standard deviation; * p < 0.05.Page 2 of 8
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as well as male CFs (3. 81 pg +/- 0.04 and 3. 11 pg +/- 0.
18; Figure 5), but not in IHFs (0. 2 pg +/- 0. 5 and 1. 47 +/
- 1; Figure 5).
Estrogen receptor expression
In all primary fibroblast cultures gene expression of estro-
gen receptor 1 (ESR1, NCB1 gene ID 2099) and, to a
minor extend, estrogen receptor 2 (ESR 2, NCB1 gene ID
2100) could be detected.
Discussion
In the present study the influence of estrogen on the
expression of collagen type IA1 and IIIA1 as well as matrix
metalloproteinase-2 gene was determined in four differ-
ent cell cultures. These fibroblasts were obtained from
heterogeneous donors that were distinct regarding their
history of recurrent hernia disease, sex, BMI and age. The
number of cell cultures has to be regarded as a limitation
of the study. But besides their heterogeneity, incisional
hernia fibroblasts exhibit a reduction of type I to III colla-
gen ratio on the transcriptional level in vivo. These results
confirm former studies of our group that described a sig-
nificantly reduced Type I/III collagen ratio on the protein
as well as on the transcriptional level in patients with
recurrent incisional hernia disease in vivo [11-14]. It is
remarkable that these changes were detected in the
absence of any inflammatory cells, pre-existing extracellu-
lar matrix and the lack of a three-dimensional cellular net-
Effect of β-estradiol on type I and type III collagen gene expressionFigure 3
Effect of β-estradiol on type I and type III collagen gene 
expression. Type I and III collagen mRNA was quantified 
after 24 h of stimulation with 0.25 ng/ml β-estradiol in female 
CFs (white bars), male CFs (light grey bars), female IHFs 
(dark grey bars) and male IHFs (black bars). Data are pre-
sented as means +/- standard deviation.
Collagen gene expression in primary fibroblasts from female patient without any history of herniaFigur  2
Collagen gene expression in primary fibroblasts from female patient without any history of hernia. Type I and III collagen 
mRNA was quantified in female CFs (fibroblasts derived from patients without incisional hernia) by RT-PCR analysis. A: Type I 
collagen mRNA expression; B: Type III collagen mRNA expression; white bars: no estrogen, grey bars: 0.025 ng/ml β-estradiol, 
black bars: 0.25 ng/ml β-estradiol. Data are presented as mean+/- standard deviation;*p < 0.05 vs. white bars (no estrogen).
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incisional hernia fibroblasts retain an altered phenotype
under in vitro conditions and are accessible to ample the
influence of steroidal modulation on these cells.
The basic massage of our study is that the individual can
be identified as an independent factor for the β-estradiol
induced alterations of collagen gene expression. Regard-
ing literature female sex hormones have ample effects on
cell growth and the development of connective tissue but
in vitro findings are sometimes controversial. Topical
estrogen treatment is reported to increase collagen levels,
decrease wound size and to enhance tensile strength in
both males and female [7]. In accord with this β-estradiol
application enhanced collagen gene expression in
healthy, female fibroblasts in our study but not in healthy
male donors (Figure 3). A sex dependent effect of estrogen
was described by Lee et al. who suggested that estrogen
effects on collagens is unique to females and might be
responsible for the increased incidence of ligaments
injury in female athletes [15].
Several other studies suggest that estrogens repress colla-
gen expression: In the rat hip capsule, skin, aorta, and tail
Effect of β-estradiol on MMP-2 gene expressionFigure 5
Effect of β-estradiol on MMP-2 gene expression. MMP-2 mRNA (pg/μg total RNA) was quantified by RT-PCR analysis after 24 
hours. White bars: fibroblasts without estrogen stimulation; black bars: fibroblasts after 24 hours of stimulation with 0.25 ng/ml 
β-estradiol. A: fibroblasts derived from female patients; B: fibroblasts derived from male patients; Data are presented as means 
+/- standard deviation;* p < 0.05 vs. CFs.
Effect of β-estradiol on type I/III collagen ratioFigure 4
Effect of β-estradiol on type I/III collagen ratio. Type I/III collagen mRNA (ng/μg total RNA) was quantified by RT-PCR analysis 
after 24 hours of β-estradiol stimulation. White bars: no estrogen, grey bars: 0.025 ng/ml β-estradiol, black bars: 0.25 ng/ml β-
estradiol. A: fibroblasts derived from female patients; B: fibroblasts derived from male patients; Data are presented as means +/
- standard deviation; *p < 0.05 vers. CFs.
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decrease in the total amount of collagen [16,17]. Hassager
et al. demonstrated that oral estrogen therapy significantly
reduces type I procollagen in postmenopausal women
and increases total body type III collagen content in a sim-
ilar group of patients [18,19]. Yu and co-workers estab-
lished fibroblast cultures from the anterior cruciate
ligament and reported a decreased type I procollagen syn-
thesis with increasing estradiol levels whereas no differ-
ences in type III collagen synthesis were detected [20]. In
accordance we found that β-estradiol at a concentration of
0.025 ng/ml and 0.25 ng/ml had no effect on type IA1/III
collagen mRNA ratio in control fibroblasts nor in inci-
sional hernia fibroblasts (Figure 4). In conclusion these
date indicate that estrogen is inappropriate to reverse the
impaired type I/III collagen ratio in hernia fibroblasts.
Regarding these reports, a further decrease of type I/III col-
lagen ratio in dependence of estrogen incubation is absent
for hernia fibroblasts and estrogen seems to be of minor
importance for the occurrence of the hernia fibroblast
phenotype.
The collagens are under control of a degradation system,
the main constituents of which are matrix metalloprotei-
nases (MMPs) [21]. MMPs are essential for the proper pro-
gression of wound healing [22]. Of note, there is a direct
link between MMP-2 and collagen gene expression as col-
lagen binding to discoidin domain receptor II (DDR 2)
regulates MMP-2 gene transcription [23]. A former study
of our group investigated the biomaterial induced MMP-2
mRNA expression in incisional hernia fibroblasts and
detected no alterations of their MMP-2 synthesis com-
pared to control fibroblasts [24]. In contrast, Bellon et al.
have suggested that high expression levels of metallopro-
teinase 2 (MMP-2) in fibroblasts play a pathogenetic role
for hernia formation [4]. Here, we found that incisional
hernia fibroblasts exhibit a decreased MMP-2 gene expres-
sion. One should take into consideration that the epide-
miological data of fibroblast donors vary concerning age,
BMI and history of smoking or co- medication and this
heterogeneity might explain these differences. As hernia
disease predominantly occurs in elderly patients it seems
difficult to rule out that 'controls' are affected patients in
future. Therefore controls should be defined as patients
that are older than 60 years and underwent an abdominal
incision about a decade ago. Nevertheless, collagen ration
proves true as an important diagnostic tool for incisional
hernia disease.
Pirila et al. reported, that MMP levels are reduced and type
I collagen content is increased in ovariectomized rats after
treatment with estrogen [10]. The authors conclude that
estrogens promote wound healing due to the inhibition
of MMP-mediated collagenolysis. In contrary, Zecchin et
al. described that ovariectomy reduces the expression of
MMP-2 and type I and III collagen in female rat molar
extraction wounds [25]. We found that β-estradiol (0.25
ng/ml) increased MMP-2 in female fibroblasts from
healthy donors. Upregulation of MMP-2 expression after
estrogen treatment has been described in breast cancer cell
and vaginal tissue samples [26,27]. In addition, a
decreased MMP-2 gelatinolytic activity has already been
described during skin wound healing of OVX rats. The
upregulation of MMP-2 and type IA1 and IIIA1 collagen
in female fibroblasts confirms the association between
estrogen and collagens, and estrogens and MMP-2. Estro-
gen receptor 1 (ESR1) and estrogen receptor 2 (ESR2),
which are present in all our primary fibroblast cultures,
might be signal transducers [28].
Conclusion
Though our in vitro study presents preliminary results, the
coherence of MMP-2 inhibition and diminished type IA1
to III collagen ratio in incisional hernia fibroblasts
approves that the expression and processing of key mole-
cules in wound healing is disturbed in hernia patients. β-
estradiol metabolism seems of minor importance for the
impaired collagen metabolism in these patients. In con-
trast to alterations of collagen metabolism in the range of
incisional hernia disease, the individual was identified as
an independent factor for the β-estradiol induced altera-
tions of collagen gene expression. The observation of gen-
der specific β-estradiol-dependent changes of collagen
gene expression has to be proven in view of the additive
effects of age, BMI, smoking or medication for future stud-
ies of cellular response.
Methods
Outgrowths of primary fibroblasts derived from abdomi-
nal skin scars of (i) a male patient without any history of
hernia; (ii) a female patient without any history of hernia;
(iii) a male patient with ten recurrent incisional hernias;
and (iv) a female patient with five recurrent incisional
hernias were established and analyzed. Patients character-
istics are provided in Table 1 (age 62.7 +/- 8.9 years, BMI
24.4 +/- 4.5). All patients were non-smokers. There was no
history of steroid medication and no history of familial
connective tissue disease. The female patients did not
receive any hormone therapy. The study was approved by
the local ethics committee and informed consent was
obtained from all patients. Scar tissue from control
patients were harvested at re-operation excluding acute
abdominal cause.
Fibroblast cultures and β-estradiol incubation
Immediately after surgical scar excision, specimens were
processed for cell culture as previously described [29]. Pri-
mary fibroblasts from the 4th to the 10th passage were
used. For the investigation of estrogen-dependent altera-
tions of type I collagen, type III collagen and MMP-2Page 5 of 8
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lasts were incubated with β-estradiol at 0.25 ng/ml or
0.025 ng/ml (Sigma, Steinheim, Germany) for 24 and 48
hours and harvested thereafter. The chosen concentra-
tions have been reported to represent physiological levels
[30]. 48 hours prior to β-estradiol incubation, fibroblasts
were held in serum free media (DMEM without phenol
red, 0.1% albumin, 0.6% mg/ml glutamine, 100–200 U/
ml penicillin, 50–100 μg/ml streptomycin). For collagen
assays, cells were cultured in 24-well plates with initial
seeding density of 10000 cells/ml. Medium volume: 0.5
ml/1.9 cm2. All cell cultures were maintained in a humid-
ified atmosphere at 37°C in 95% air and 5% CO2. Exper-
iments were carried out in triplicate with fibroblast
cultures of passage 5–10.
RNA-Isolation and reverse transcription
Total RNA was extracted from fibroblasts (RNeasyMini
Kit, Quiagen Operon, Cologne, Germany) and treated
with DNase for 20 min (RNase free DNase, Quiagen
Operon, Cologne, Germany) in order to avoid amplifica-
tion by contaminating genomic DNA. Concentration and
purity of RNA was determined by measuring absorbance
at 260 nm and 280 nm in a biophotometer (Eppendorf,
Köln, Germany). Synthesis of cDNA was catalyzed by
SuperScript II RNase H-reverse transcriptase-system (Inv-
itrogen, Carlsbad, CA, USA).
Primers and probes
Oligonucleotide primers and target specific DNA-probes
to analyze MMP-2, type IA and type IIIA1 collagen gene
expression were chosen using Primer Express Software,
Version 1.0 (Applied Biosystems, Forster City, CA, USA)
(Table 2) to span exon junctions of the target sequences.
TaqMan probes selected were fluorescence-labelled at the
5' end with 6-carboxyfluorescein (FAM) as reporter dye
and at the 3' end with 6-carboxytetramethylrhodamine
(TAMRA) as quencher. In preliminary experiments, PCR
conditions had been optimized regarding concentration
of cDNA, primers and target-specific cDNA. Expression of
estrogen receptor 1 (ESR1) and estrogen receptor 2 (ESR2)
was determined by QuantiTect HS_ESR1 and QuantiTect
HS_ESR2 gene expression assays (Qiagen, Cologne, Ger-
many). Cyclophilin was used as endogenous control.
TaqManR reverse transcriptase PCR
Quantification of cyclophilin (hCYP), type IA1 collagen,
type IIIA1 collagen, estrogen receptor 1 and 2 (ESR1 and
ESR2) and MMP-2 was performed by real time analysis
with the ABI Prism 7700 Sequence Detection System
(Applied Biosystems, Forster City, CA, USA). PCR reac-
tions were performed in a 96 well microtiter plate with
TaqMan universal PCR master mixture (Perkin-Elmer Bio-
systems) and Platinium Taq-polymerase (Platinium
Quantitative PCR SuperMix-UDG, Invitrogen, Carlsbad,
CA, USA) under the following conditions: after 2 min at
50°C and 10 min at 95°C samples were submitted to 40
cycles with each cycle consisting of a denaturizing step at
95°C for 15s followed by an annealing step at 60°C for 1
min. Analyses were performed in duplicate. N-uracil-glyc-
osylase restriction was performed to avoid contamination
of the sample DNA with other DNA amplificates.
Quantification of mRNA expression
Type 1A1 and Type IIIA1 Collagen Gene, estrogen recep-
tor 1 and 2 (ESR1 and ESR2):
Levels of mRNA for type IA1 and IIIA1 collagen, ESR1 and
ESR2 are expressed semiquantitatively in relative copy
numbers normalized against the housekeeping gene
cyclophilin (comparative CT method).
MMP-2 gene expression
Levels of mRNA for MMP-2 were expressed in ng/μg RNA
as absolute quantification. To this end a standard curve
from serial dilutions of a purified target-specific cDNA
was performed for each PCR reaction. cDNA probes were
obtained by amplification, cloning into a pGEMT Vector,
preparation of plasmid DNA and sequencing.
Data analysis was performed by the Sequence Detection
System Software, Version 1.6 (Applied Biosystems, Forster
City, CA, USA).
Statistics
Explorative analysis of data was performed using Statisti-
cal Package for Social Sciences (SPSS®) – software. The sta-
tistical analysis compared three independent experiments
and data were organized according to type of primary
fibroblast cell culture and β-estradiol stimulation. P val-
ues less than 0.05 were considered to be significant. All
data are presented as mean values +/- standard deviation.
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